Bill Detail

H.Res. 1285

Congress: 119

Title

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Summary

No summary published on Congress.gov yet — common for recently introduced bills.

Sponsor

Rep. Diana DeGette [D-CO-1]

Status

Referred to the House Committee on Energy and Commerce.

Status as of Jun 19, 10:00 AM · synced 10d ago

Introduced

2026-05-14

Data source mode: congress-gov

Bill Engagement